Clear implications for enalapril in chronic heart failure Newsletter Article 13 February 2013 Pages: 2 - 3
Sotalol - a rising star in the treatment of arrhythmia? Gill Higgins Newsletter Article 13 February 2013 Pages: 3 - 5
New evidence adds weight to the Helicobacter pylori story Tracey TaylorToni Milne Newsletter Article 13 February 2013 Pages: 5 - 7
Aciclovir expensive and possibly ineffective in chickenpox Newsletter Article 13 February 2013 Pages: 8 - 8
An orally active colforsin derivative shows potential in heart failure Newsletter Article 13 February 2013 Pages: 11 - 11
ICI’s meropenem treats Pseudomonas aeruginosa meningitis Newsletter Article 13 February 2013 Pages: 12 - 12
A model for a new class of antihypertensive agents? Newsletter Article 13 February 2013 Pages: 12 - 12
β-blockers, digitalis or both after coronary bypass? Newsletter Article 13 February 2013 Pages: 13 - 13
Inositol supplementation recommended in premature neonates Newsletter Article 13 February 2013 Pages: 13 - 13
… tamoxifen without surgery is not justified in elderly patients Newsletter Article 13 February 2013 Pages: 16 - 16
‘Cefzil’ - a valuable antibacterial say manufacturers Newsletter Article 13 February 2013 Pages: 18 - 18
Enalapril’s place in antihypertensive therapy defined Newsletter Article 13 February 2013 Pages: 19 - 19
Inhaler timer device useful check on MDI compliance Newsletter Article 13 February 2013 Pages: 20 - 20
Shorter courses of terbinafine proposed for fungal nail infections Newsletter Article 13 February 2013 Pages: 21 - 21
Epicardial iontophoretic procainamide delivery feasible Newsletter Article 13 February 2013 Pages: 21 - 21
Desipramine a potential alternative to amitriptyline in diabetic neuropathy Newsletter Article 13 February 2013 Pages: 22 - 22